A number of upcoming U.S. initial public offerings, including $15B fintech Klarna (KLAR) and $50B medtech company Medline, have been postponed as Donald Trump’s aggressive tariffs roil global financial markets, according to people familiar with the matter, The Financial Times’ Akila Quinio and Arash Massoudi in London and Oliver Barnes and George Steer in New York report. Private equity-backed surgical products company Medline intended to go public but those plans have now been put on hold due to market turbulence, sources said. Medline, which is backed by Blackstone (BX) and Carlyle (CG), planned to file publicly earlier this week, aiming at a valuation of approaching $50B, but the listing has now been delayed indefinitely.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BX:
- Rogers Communications concludes agreement for C$7B equity investment
- Blackstone price target lowered to $207 from $219 at BofA
- Trump close to revealing plan to spare TikTok from ban, Bloomberg says
- Blackstone weighs sale of AirTrunk data centers, Bloomberg reports
- Private Equity Stocks Crash as Tariffs Threaten Dealmaking for KKR and Apollo